Arcadia Biosciences's market cap is currently $4.76M. The company's EPS TTM is $-3.26; its P/E ratio is ―; Arcadia Biosciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
